» Authors » S Viswanathan

S Viswanathan

Explore the profile of S Viswanathan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 119
Citations 2139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein J, Tran W, Viswanathan S, Salgado R, Poortmans P, Machiels M
Clin Oncol (R Coll Radiol) . 2025 Jan; 39:103742. PMID: 39854781
Aim: Tumour-infiltrating lymphocytes (TILs) represent a promising cancer biomarker. Different TILs, including CD8+, CD4+, CD3+, and FOXP3+, have been associated with clinical outcomes. However, data are lacking regarding the value...
2.
Sathya T, Viswanathan S, Kolar A, Jahirhussain G, Alagumanian S, Sobana S, et al.
Environ Res . 2024 Jun; 259:119445. PMID: 38942259
In present investigation, Carica papaya leaf extract has been employed as a bio-reductant agent in order to synthesize ecologically sustainable bio-coupled gold nanoparticles. The formation of gold nanoparticles was confirmed...
3.
4.
Thompson D, Bach M, McAnany J, Sustar Habjan M, Viswanathan S, Robson A
Doc Ophthalmol . 2024 Mar; 148(2):75-85. PMID: 38488946
The pattern electroretinogram (PERG) is a localized retinal response evoked by a contrast-reversing pattern, usually a black and white checkerboard, which provides information about macular and retinal ganglion cell function....
5.
Albart S, Yusof Khan A, Wan Zaidi W, Muthuppalaniappan A, Kandavello G, Koh G, et al.
Med J Malaysia . 2023 Jun; 78(3):389-403. PMID: 37271850
Introduction: About 20 to 40% of ischaemic stroke causes are cryptogenic. Embolic stroke of undetermined source (ESUS) is a subtype of cryptogenic stroke which is diagnosed based on specific criteria....
6.
Ong Z, Arip M, Ching Y, Kumar L, Terumalay S, Sim S, et al.
Mult Scler Relat Disord . 2022 Oct; 67:104168. PMID: 36274473
Introduction: CNS IIDDs tested positive for anti-MOG are known to have a distinct clinical profile with a better overall prognosis. Objectives: We aim to determine the prevalence, demographic and clinical...
7.
Banh L, Cheung K, Chan M, Young E, Viswanathan S
Osteoarthritis Cartilage . 2022 Apr; 30(8):1050-1061. PMID: 35460872
Joint-on-a-chip (JOC) models are powerful tools that aid in osteoarthritis (OA) research. These microfluidic devices apply emerging organ-on-a-chip technology to recapitulate a multifaceted joint tissue microenvironment. JOCs address the need...
8.
Krishnan D, Viswanathan S, Rose N, Benjamin H, Ong A, Hiew F
BMC Neurol . 2021 Sep; 21(1):366. PMID: 34548039
Background: Spinal AVF (SAVF), a potentially treatable cause of myelopathy, remains a challenging diagnosis. Its rarity and non-specific imaging findings often result in misdiagnosis despite a high index of clinical...
9.
Chan M, Gomez-Aristizabal A, Mahomed N, Gandhi R, Viswanathan S
Osteoarthritis Cartilage . 2021 Sep; 30(1):147-159. PMID: 34547432
Objective: There is a need to incorporate multiple tissues into in vitro OA models to evaluate novel therapeutics. This approach is limited by inherent donor variability. We present an optimized...
10.